Beyond Histologic Staging: Emerging Imaging Strategies in Colorectal Cancer with Special Focus on Magnetic Resonance Imaging

Tyler J. Fraum, Joseph W. Owen, Kathryn J. Fowler

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Imaging plays an increasingly important role in the staging and management of colorectal cancer. In recent years, magnetic resonance imaging (MRI) has supplanted transrectal ultrasound as the preferred modality for the locoregional staging of rectal cancer. Furthermore, the advent of both diffusion-weighted imaging and hepatobiliary contrast agents has significantly enhanced the ability of MRI to detect colorectal liver metastases. In clinical practice, MRI routinely provides prognostic information, helps to guide surgical strategy, and determines the need for neoadjuvant therapies related to both the primary tumor and metastatic disease. Expanding on these roles for MRI, positron emission tomography (PET)/MRI is the newest clinical hybrid imaging modality and combines the metabolic information of PET with the high soft tissue contrast of MRI. The addition of PET/MRI to the clinical staging armamentarium has the potential to provide comprehensive state-of-the-Art colorectal cancer staging in a single examination.

Original languageEnglish
Pages (from-to)205-215
Number of pages11
JournalClinics in Colon and Rectal Surgery
Volume29
Issue number3
DOIs
StatePublished - Sep 1 2016

Keywords

  • MRI
  • circumferential margin
  • colorectal cancer staging
  • transrectal ultrasound

Fingerprint

Dive into the research topics of 'Beyond Histologic Staging: Emerging Imaging Strategies in Colorectal Cancer with Special Focus on Magnetic Resonance Imaging'. Together they form a unique fingerprint.

Cite this